Dose Escalation and Dose Expansion Study of MDX2004 in Participants With Advanced Tumors
Clinical trial NCT07110584 · RECRUITING
Trial details
- NCT number
- NCT07110584
- Sponsor
- ModeX Therapeutics, An OPKO Health Company
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-10-01
- Primary completion
- 2031-06-30
- Enrollment
- 235
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.